A comparison between two companies CADX and PCRX
CADX Ofirmev cost $10. per dose and can be done anywhere in hospital 2013 earnings estimate loss .$.29 on revenue of 108.5 million and 2014 earnings gain $.10 on revenue of 170 million float 62 plus million shares. 2014 whisper earnings loss $.03 Float 62 million plus shares Price target $11
PCRX Exparel cost $300 a dose limited where can and who can apply. 2013 loss of $1.87 on revenue of 80 million, 2014 loss of $.06 on revenue of 169 million 2014 Whisper earnings loss of $.33 Target high estimate $60 float 31.6 million shares current price $55 plus target $60 Exparel has the potential of being used in other Pain Management procedures according to my son anesthesiologist
As an anesthesiologist I can tell you experel is a very cool drug, but I don't see it gaining the widespread that Ofirmev has already. We have known about it for a while. If you are depositing bupivicane you are preventing incisional pain. Unless you are just sewing up a cut in the ER there is going to be pain from the rest of the procedure. $300 a dose for incisional pain relief seems excessive. Also people are sa little scared of the cardiac side effects if bupivicane, but that's another story.